Akero Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Akero Therapeutics, Inc. has filed 734 SEC EDGAR filings since 18 Dec 2018

SEC filing history

Showing 351-375 of 734 matching filings.

Per page
25
Current page
15
4

4

Filing date
27 Jun 2023
Reporting date
23 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
27 Jun 2023
Reporting date
23 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
27 Jun 2023
Reporting date
23 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
27 Jun 2023
Reporting date
23 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38944

144 filing

Filing date
26 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 Jun 2023
Reporting date
21 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
22 Jun 2023
Reporting date
20 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
21 Jun 2023
Reporting date
16 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
21 Jun 2023
Reporting date
16 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
21 Jun 2023
Reporting date
16 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38944

144 filing

Filing date
20 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38944

144 filing

Filing date
16 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38944

144 filing

Filing date
16 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38944

144 filing

Filing date
16 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38944

144 filing

Filing date
16 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Jun 2023
Reporting date
13 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Jun 2023
Reporting date
13 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Jun 2023
Reporting date
13 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Jun 2023
Reporting date
13 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Jun 2023
Reporting date
13 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A SUBMISSION

Filing date
15 Jun 2023
Reporting date
19 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 Jun 2023
Reporting date
01 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 May 2023
Reporting date
19 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .